NeuroproteXeon Overview

  • Founded
  • 2014

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

NeuroproteXeon General Information

Description

Provider of late clinical-stage pharmaceutical and medical devices based in New York. The company's inhalation device protects against brain cell death following acute neurologic injury.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Discovery
Acquirer
Invero Pharma
Primary Office
  • 50 Cobham Drive
  • Orchard Park
  • New York, NY 14127
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroproteXeon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroproteXeon‘s full profile, request access.

Request a free trial